Tirzepatide – 40mg

Tirzepatide is a dual incretin peptide designed to activate GLP-1 (glucagon-like peptide-1)
and GIP (glucose-dependent insulinotropic polypeptide) receptors.
This dual mechanism of action has made it a highly valuable compound for research into
weight management, insulin sensitivity, and metabolic regulation.
At 40mg, Tirzepatide offers a mid-range dosage option for extensive scientific exploration.

Potential Research Benefits

• Studied for weight loss & appetite control
• Explored for insulin sensitivity & glucose balance
• Supports lipid metabolism research
• Dual receptor activity: GLP-1 & GIP

Scientific Background

By engaging both GLP-1 and GIP receptors, Tirzepatide may provide synergistic effects
on metabolism that go beyond single-agonist peptides. Research has indicated improvements
in body weight reduction, appetite regulation, and glycemic control.
Its dual-incretin design has positioned it as a leading compound of interest
in metabolic and obesity-related studies.

Product Details

• Compound: Tirzepatide
• Form: Lyophilized Powder
• Amount: 40mg per vial
• Purity: ≥99%
• Appearance: White to off-white powder
• Research Use Only: Not for human consumption